Abiopharma

🔍 Retort Vincent (Executive)

Company: Lumentum Holdings Inc. (LITE)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 360 shares of Common Stock at $842.2161 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 116,743.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,213 shares of Common Stock at $843.6014 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 115,530.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,053 shares of Common Stock at $844.6082 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 114,477.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 631 shares of Common Stock at $845.6299 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 113,846.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 2,073 shares of Common Stock at $846.4448 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 111,773.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,121 shares of Common Stock at $847.516 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 109,652.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 1,102 shares of Common Stock at $848.6576 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 108,550.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 1,528 shares of Common Stock at $849.7055 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 107,022.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 3,017 shares of Common Stock at $850.6556 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 104,005.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 4,426 shares of Common Stock at $851.6762 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 99,579.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 3,711 shares of Common Stock at $852.6005 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 95,868.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 2,465 shares of Common Stock at $853.6179 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 93,403.00 | transaction_form_type: 4 | Footnotes: F1, F13
• Sold 3,486 shares of Common Stock at $854.8859 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 89,917.00 | transaction_form_type: 4 | Footnotes: F1, F14
• Sold 800 shares of Common Stock at $855.8411 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 89,117.00 | transaction_form_type: 4 | Footnotes: F1, F15
• Sold 4,676 shares of Common Stock at $856.7089 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 84,441.00 | transaction_form_type: 4 | Footnotes: F1, F16
• Sold 3,511 shares of Common Stock at $857.95 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 80,930.00 | transaction_form_type: 4 | Footnotes: F1, F17
• Sold 188 shares of Common Stock at $858.8163 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 80,742.00 | transaction_form_type: 4 | Footnotes: F1, F18
• Sold 2,302 shares of Common Stock at $860.052 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 78,440.00 | transaction_form_type: 4 | Footnotes: F1, F19

Footnotes:

• F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.
• F2: These sales were executed in multiple trades at prices ranging from $841.745 to $842.695. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price, within the ranges set forth in footnotes (2) through (19) to this Form 4, upon request, to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer.
• F3: These sales were executed in multiple trades at prices ranging from $843.00 to $843.93.
• F4: These sales were executed in multiple trades at prices ranging from $844.00 to $844.93.
• F5: These sales were executed in multiple trades at prices ranging from $845.00 to $845.99.
• F6: These sales were executed in multiple trades at prices ranging from $846.00 to $846.99.
• F7: These sales were executed in multiple trades at prices ranging from $847.00 to $847.99.
• F8: These sales were executed in multiple trades at prices ranging from $848.075 to $849.05.
• F9: These sales were executed in multiple trades at prices ranging from $849.08 to $850.03.
• F10: These sales were executed in multiple trades at prices ranging from $850.17 to $851.04.
• F11: These sales were executed in multiple trades at prices ranging from $851.175 to $852.17.
• F12: These sales were executed in multiple trades at prices ranging from $852.175 to $853.17.
• F13: These sales were executed in multiple trades at prices ranging from $853.18 to $854.17.
• F14: These sales were executed in multiple trades at prices ranging from $854.295 to $855.17.
• F15: These sales were executed in multiple trades at prices ranging from $855.41 to $856.2725.
• F16: These sales were executed in multiple trades at prices ranging from $856.46 to $857.43.
• F17: These sales were executed in multiple trades at prices ranging from $857.53 to $858.51.
• F18: These sales were executed in multiple trades at prices ranging from $858.595 to $859.42.
• F19: These sales were executed in multiple trades at prices ranging from $859.99 to $860.83.
• REMARKS: Officer title: Executive Vice President, Global Reliability & Quality